Q32 Bio, Inc. (QTTB)
8.62
+0.83
(+10.65%)
USD |
NASDAQ |
Oct 20, 16:00
8.54
-0.08
(-0.93%)
After-Hours: 07:37
Q32 Bio Gross Profit (TTM) : 53.38M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.38M |
| March 31, 2026 | 53.38M |
| December 31, 2025 | 53.35M |
| September 30, 2025 | -0.421M |
| June 30, 2025 | -0.453M |
| March 31, 2025 | -0.483M |
| December 31, 2024 | -0.487M |
| September 30, 2024 | -15.15M |
| June 30, 2024 | -13.30M |
| March 31, 2024 | -10.09M |
| December 31, 2023 | -7.15M |
| September 30, 2023 | 7.805M |
| June 30, 2023 | 6.237M |
| March 31, 2023 | 3.172M |
| December 31, 2022 | 0.609M |
| September 30, 2022 | -1.153M |
| June 30, 2022 | -1.32M |
| March 31, 2022 | -1.336M |
| Date | Value |
|---|---|
| December 31, 2021 | -1.593M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.6028M |
| September 30, 2018 | 0.402M |
| June 30, 2018 | 0.202M |
| March 31, 2018 | 0.202M |
| December 31, 2017 | -0.4008M |
| September 30, 2017 | -0.20M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 44.25M |
| Beam Therapeutics, Inc. | 133.79M |
| Prime Medicine, Inc. | -3.325M |
| Prelude Therapeutics, Inc. | 20.84M |
| Twist Bioscience Corp. | 224.38M |